Indian patent office rejection of Gilead’s hepatitis C drug: How it will affect the poor?

January 15, 2015 3:44 PM

4 0

Indian patent office rejection of Gilead’s hepatitis C drug: How it will affect the poor?

India is a nation that has been taking the lead when it comes to relatively cheap and affordable medicines. This seems to be the reasoning behind India patent office’s latest verdict.

Read more

To category page

Loading...